Table 2.
Applications of stem cells in concert with hydrogels.
Cell type | Material | Study | Peptide | Pores (μm) | Ref |
---|---|---|---|---|---|
MSCs | Silk | Tissue engineering with silk hydrogels | RGD | ∼200 | [102] |
PCL | A variation of pore size | RGD | 100–450 | [154] | |
PEG | Injectable Biodegradable hydrogel deposits | ∼500 | [103] | ||
HA | Functionalized hydrogel with mimetic peptide | N-Cadherin & RGD | [33] | ||
NapFF-NO | Nitric oxide releasing hydrogels | FFGGG | [4] | ||
CS | Affinity peptide bone matrix, with CS hydrogel | E7 | 30–80 | [135] | |
Agarose | Biomimetic hydrogel delivers factors | RGD | [10] | ||
PEG and CS | Controlling porosity of hydrogels | 180–240 | [2] | ||
PEG | Evaluation of macroporous hydrogel | RGD | 100–600 | [7] | |
NSCs | Agarose | The Effect of growth factor on NSCs | GRGD | [9] | |
SAP | Encapsulated NSCs in SAP hydrogel | IKVAV | [15] | ||
Gel-HPA | Effect of injectable hydrogel on proliferation | RGD | ∼3 | [106] | |
Alginate | Promotion of oriented axonal regrowth | ∼27 | [12] | ||
ESCs | PHEMA | Polymers for ES cell use | 100–500 | [8] | |
PHEMA | Templates for cardiac tissue engineering | 20–80 | [114] | ||
iPSCs | HA | Hydrogel promotes early survival of iPSC | RGD | [115] | |
PEG | Reprogramming mouse fibroblasts | RGD | [13] | ||
ASCs | HA | Thermosensitive injectable HA hydrogel | 3–20 | [5] |